The COA, which details the independent third-party purity testing results, can be provided upon request to ensure your laboratory's internal compliance and publication requirements are fully met
Malone, M
Oral formulations rely on passive absorption but, owing to the pathophysiology of the condition, patients with pernicious anaemia will only absorb around 1% of an orally administered dose[23]
Targeted Pigmentation Reduction: Say goodbye to dark spots and uneven skin tone as our cream lightens pigmentation and evens out skin tone, revealing a more radiant complexion
Mold Immune Reactivity IgE: Cladosporium herbarum : 2.4 Penicillium chrysogen : 4.1 Remaining panel: negative IgG: Broad elevation across multiple molds (including Cladosporium, Aspergillus, Setomelanomma, Curvularia ) Clinical Interpretation of Findings Indicated: Strong mold-specific immune sensitization Intermediate Intervention: Immune Modulation and Neuroregulation Oral immunotherapy (1 5 drops over 5 weeks) L-theanine 200 mg three times daily Clinical Response: Substantial reduction in anxiety Improved cognitive clarity Improved emotional stability Escalation of Binding Therapy Cholestyramine introduced Clinical Response (2 months): Resolution of fatigue Resolution of pain Improved GI symptoms Reduced food intolerance Final Intervention: Glutathione IV glutathione titrated from 1000 mg 3000 mg over 6 weeks Clinical Response: Resolution of insomnia Outcome Neuropsychiatric symptoms resolved Systemic symptoms improved Sleep normalized Discussion Objective improvement may precede symptom resolution Early reductions in C4a and TGF-1 suggest physiologic improvement before full clinical recovery
Low bioavailability does not necessarily prevent clinical utility, as demonstrated by desmopressin and calcitonin
